Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
Sell
33
GPCR Quote, Financials, Valuation and Earnings
Last price:
$21.05
Seasonality move
:
47.59%
Day range:
$20.85 - $22.25
52-week range:
$19.39 - $62.74
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.44x
Volume:
325.3K
Avg. volume:
816.6K
1-year change:
-38.18%
Market cap:
$1.2B
Revenue:
--
EPS (TTM):
-$2.35
Earnings Data
Next earnings date for GPCR
May 09
2025
Most recent earnings per share
-$0.64
Missed by $0.47
(Feb 27/2025)
Consensus Estimate
-$0.17
(Feb 27/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
GPCR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/09/2025 | Q1 | -- | -- | -- | -$0.23 | -- |
| 02/27/2025 | Q4 | -- | -- | -$0.64 | -$0.17 | -$0.47 |
| 11/13/2024 | Q3 | -- | -- | -$0.60 | -$0.19 | -$0.41 |
| 08/08/2024 | Q2 | -- | -- | -$0.54 | -$0.23 | -$0.32 |
| 05/09/2024 | Q1 | -- | -- | -$0.57 | -$0.22 | -$0.35 |
| 03/08/2024 | Q4 | -- | -- | -$0.48 | -$0.21 | -$0.27 |
| 11/17/2023 | Q3 | -- | -- | -$0.63 | -$0.22 | -$0.41 |
| 08/10/2023 | Q2 | -- | -- | -$0.60 | -$0.27 | -$0.33 |
| 05/11/2023 | Q1 | -- | -- | -$0.75 | -$0.37 | -$0.38 |
| 12/31/2022 | Q4 | -- | -- | -$0.31 | -$0.54 | $0.23 |
| 09/30/2022 | Q3 | -- | -- | -$0.49 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.61 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.51 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.61 | -- | -- |
Structure Therapeutics Earnings Questions
-
How Much did Structure Therapeutics Generate in Revenue Last Quarter?
Structure Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Structure Therapeutics Beat Earnings Last Quarter?
Structure Therapeutics announced earnings per share of -$0.64 which represents a miss of analyst forecast a -$0.17 per share.
-
Is Structure Therapeutics Profitable?
Structure Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Structure Therapeutics EPS Next Year?
Structure Therapeutics's earnings are forecast to decrease from -$2.34 per share to -$0.76 per share next year representing a decrease of -70.86%.
-
When is Structure Therapeutics's Earnings Date?
Structure Therapeutics's next earnings date is May 9, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Is Ford Stock Undervalued Amid the EV Transition?
There is a lot going on in the electric vehicle…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
Sell
47
CELH alert for Mar 18
Celsius Holdings [CELH] is up 1.44% over the past day.
